Intravenous antibiotics for chronic rhinosinusitis: are they effective?
OBJECTIVE
Antibiotics have been used commonly in chronic rhinosinusitis, often because chronic rhinosinusitis has features of a prolonged bacterial sinusitis, including abnormal CT findings and positive bacterial cultures. The advent of peripherally inserted central catheters has enabled outpatient parenteral antibiotic therapy to become a convenient means of delivering potent antibiotics for various conditions when oral antibiotics may not be effective or appropriate. Chronic rhinosinusitis has been included as a condition that may benefit from outpatient parenteral antibiotic therapy; however, there are few studies that document its success and, furthermore, chronic rhinosinusitis may not always be an infectious process.


RESULTS
Three recent uncontrolled retrospective studies examined outpatient parenteral antibiotic therapy in chronic rhinosinusitis. In one series outpatient parenteral antibiotic therapy was used as an adjunct to sinus surgery, in another it was used as an alternative to sinus surgery in the pediatric population, and in the third it was used as temporary resolution for adult patients who had failed other therapies including sinus surgery. Short-term success rates were reported in the range of 29 to 89%, but relapse rates were as high as 89%. Complication rates in theses studies ranged from 14 to 26%, including medication reactions and intravenous line problems.


CONCLUSIONS
The role of outpatient parenteral antibiotic therapy in the treatment of chronic rhinosinusitis has not been universally established. Although outpatient parenteral antibiotic therapy may have a role in avoiding sinus surgery in select pediatric populations, the contribution to a lasting resolution in adult patients is less clear and there are possible complications. Recognizing subsets of chronic rhinosinusitis patients for whom outpatient parenteral antibiotic therapy is appropriate will be the challenge for the future.
Tanner
S Bobo
SB
Vanderbilt University, Nashville, Tennessee, USA. bobotan@vasap.asapp.com
Fowler
Kathleen C
KC
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D002908:Chronic Disease; D006801:Humans; D007262:Infusions, Intravenous; D012220:Rhinitis / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D012852:Sinusitis / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents